• 时尚资讯
  • 九块邮
  • 手机版
    • 最新折扣
    • 好券直播
    • 品牌券
    • 20封顶
    • 更多导航
      热门活动热门标签
    积分商城
    • 全部>“Profile” 共876个商品
      • 默认
      • 销量
      • 价格
    • 预订 VYNDAMAX (tafamidis) Drug Profile, 2025: VYNDAMAX (tafamidis) drug patents, litigation, SPCs, suppliers, API source

      tafamidisVYNDAMAXDruglitigation

      预订 VYNDAMAX (tafamidis) Drug Profile, 2025: VYNDAMAX (tafamidis) drug patents, litigation, SPCs, suppliers, API source

      ¥3,155券后¥3,3150人已购买
      优惠券¥160 领券购买 
    • 预订 XCOPRI (cenobamate) Drug Profile, 2025: XCOPRI (cenobamate) drug patents, SPCs, clinical trials, drug prices, drug

      DrugcenobamateXCOPRI预订

      预订 XCOPRI (cenobamate) Drug Profile, 2025: XCOPRI (cenobamate) drug patents, SPCs, clinical trials, drug prices, drug

      ¥3,155券后¥3,3150人已购买
      优惠券¥160 领券购买 
    • 预订 NUBEQA (darolutamide) Drug Profile, 2025: NUBEQA (darolutamide) drug patents, SPCs, clinical trials, drug prices, s

      darolutamideDrugNUBEQA预订

      预订 NUBEQA (darolutamide) Drug Profile, 2025: NUBEQA (darolutamide) drug patents, SPCs, clinical trials, drug prices, s

      ¥3,155券后¥3,3150人已购买
      优惠券¥160 领券购买 
    • 预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      lefamulinXENLETAacetateDrug

      预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      ¥3,155券后¥3,3150人已购买
      优惠券¥160 领券购买 
    • 预订 BEYAZ (drospirenone; ethinyl estradiol; levomefolate calcium) Drug Profile, 2025: BEYAZ (drospirenone; ethinyl estr

      drospirenoneethinylBEYAZlevomefolate

      预订 BEYAZ (drospirenone; ethinyl estradiol; levomefolate calcium) Drug Profile, 2025: BEYAZ (drospirenone; ethinyl estr

      ¥3,156券后¥3,3160人已购买
      优惠券¥160 领券购买 
    • 预订 EDURANT (rilpivirine hydrochloride) Drug Profile, 2025: EDURANT (rilpivirine hydrochloride) drug patents, litigatio

      hydrochloriderilpivirineEDURANTDrug

      预订 EDURANT (rilpivirine hydrochloride) Drug Profile, 2025: EDURANT (rilpivirine hydrochloride) drug patents, litigatio

      ¥3,156券后¥3,3160人已购买
      优惠券¥160 领券购买 
    • 预订 SOLOSEC (secnidazole) Drug Profile, 2025: SOLOSEC (secnidazole) drug patents, clinical trials, drug prices, drug pr

      DrugsecnidazoleSOLOSEC预订

      预订 SOLOSEC (secnidazole) Drug Profile, 2025: SOLOSEC (secnidazole) drug patents, clinical trials, drug prices, drug pr

      ¥3,156券后¥3,3160人已购买
      优惠券¥160 领券购买 
    • 预订 TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical tr

      plecanatideTRULANCEDruglitigation

      预订 TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical tr

      ¥3,158券后¥3,3180人已购买
      优惠券¥160 领券购买 
    • 预订 TYMLOS (abaloparatide) Drug Profile, 2025: TYMLOS (abaloparatide) drug patents, litigation, SPCs, clinical trials,

      abaloparatideTYMLOSDruglitigation

      预订 TYMLOS (abaloparatide) Drug Profile, 2025: TYMLOS (abaloparatide) drug patents, litigation, SPCs, clinical trials,

      ¥3,158券后¥3,3180人已购买
      优惠券¥160 领券购买 
    • 预订 UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug

      ubrogepantDrugUBRELVYlitigation

      预订 UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug

      ¥3,158券后¥3,3180人已购买
      优惠券¥160 领券购买 
    • 预订 AIRDUO RESPICLICK (fluticasone propionate; salmeterol xinafoate) Drug Profile, 2025: AIRDUO RESPICLICK (fluticasone

      fluticasoneRESPICLICKAIRDUOpropionate

      预订 AIRDUO RESPICLICK (fluticasone propionate; salmeterol xinafoate) Drug Profile, 2025: AIRDUO RESPICLICK (fluticasone

      ¥3,159券后¥3,3190人已购买
      优惠券¥160 领券购买 
    • 预订 NUCYNTA ER (tapentadol hydrochloride) Drug Profile, 2025: NUCYNTA ER (tapentadol hydrochloride) drug patents, paten

      hydrochloridetapentadolNUCYNTADrug

      预订 NUCYNTA ER (tapentadol hydrochloride) Drug Profile, 2025: NUCYNTA ER (tapentadol hydrochloride) drug patents, paten

      ¥3,159券后¥3,3190人已购买
      优惠券¥160 领券购买 
    • 预订 SOFDRA (sofpironium bromide) Drug Profile, 2025: SOFDRA (sofpironium bromide) drug patents, suppliers: 979831005825

      sofpironiumbromideSOFDRADrug

      预订 SOFDRA (sofpironium bromide) Drug Profile, 2025: SOFDRA (sofpironium bromide) drug patents, suppliers: 979831005825

      ¥3,159券后¥3,3190人已购买
      优惠券¥160 领券购买 
    • 预订 AKYNZEO (netupitant; palonosetron hydrochloride) Drug Profile, 2025: AKYNZEO (netupitant; palonosetron hydrochlorid

      palonosetronnetupitantAKYNZEOhydrochloride

      预订 AKYNZEO (netupitant; palonosetron hydrochloride) Drug Profile, 2025: AKYNZEO (netupitant; palonosetron hydrochlorid

      ¥3,159券后¥3,3190人已购买
      优惠券¥160 领券购买 
    • 预订 BELEODAQ (belinostat) Drug Profile, 2025: BELEODAQ (belinostat) drug patents, patent challenges, litigation, clinic

      belinostatBELEODAQDrugchallenges

      预订 BELEODAQ (belinostat) Drug Profile, 2025: BELEODAQ (belinostat) drug patents, patent challenges, litigation, clinic

      ¥3,159券后¥3,3190人已购买
      优惠券¥160 领券购买 
    • 预订 BAFIERTAM (monomethyl fumarate) Drug Profile, 2025: BAFIERTAM (monomethyl fumarate) drug patents, clinical trials,

      monomethylBAFIERTAMfumarateDrug

      预订 BAFIERTAM (monomethyl fumarate) Drug Profile, 2025: BAFIERTAM (monomethyl fumarate) drug patents, clinical trials,

      ¥3,160券后¥3,3200人已购买
      优惠券¥160 领券购买 
    • 预订 AURYXIA (ferric citrate) Drug Profile, 2025: AURYXIA (ferric citrate) drug patents, litigation, clinical trials, dr

      AURYXIAcitrateferricDrug

      预订 AURYXIA (ferric citrate) Drug Profile, 2025: AURYXIA (ferric citrate) drug patents, litigation, clinical trials, dr

      ¥3,160券后¥3,3200人已购买
      优惠券¥160 领券购买 
    • 预订 ERLEADA (apalutamide) Drug Profile, 2025: ERLEADA (apalutamide) drug patents, litigation, SPCs, clinical trials, su

      apalutamideERLEADADruglitigation

      预订 ERLEADA (apalutamide) Drug Profile, 2025: ERLEADA (apalutamide) drug patents, litigation, SPCs, clinical trials, su

      ¥3,161券后¥3,3210人已购买
      优惠券¥160 领券购买 
    • 预订 TAVALISSE (fostamatinib disodium) Drug Profile, 2025: TAVALISSE (fostamatinib disodium) drug patents, litigation, S

      fostamatinibTAVALISSEdisodiumDrug

      预订 TAVALISSE (fostamatinib disodium) Drug Profile, 2025: TAVALISSE (fostamatinib disodium) drug patents, litigation, S

      ¥3,161券后¥3,3210人已购买
      优惠券¥160 领券购买 
    • 预订 SYNJARDY (empagliflozin; metformin hydrochloride) Drug Profile, 2025: SYNJARDY (empagliflozin; metformin hydrochlor

      empagliflozinmetforminSYNJARDYhydrochloride

      预订 SYNJARDY (empagliflozin; metformin hydrochloride) Drug Profile, 2025: SYNJARDY (empagliflozin; metformin hydrochlor

      ¥3,161券后¥3,3210人已购买
      优惠券¥160 领券购买 
    • 预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      delafloxacinmeglumineBAXDELADrug

      预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      ¥3,162券后¥3,3220人已购买
      优惠券¥160 领券购买 
    • 预订 TEPMETKO (tepotinib hydrochloride) Drug Profile, 2025: TEPMETKO (tepotinib hydrochloride) drug patents, SPCs, drug

      hydrochloridetepotinibTEPMETKODrug

      预订 TEPMETKO (tepotinib hydrochloride) Drug Profile, 2025: TEPMETKO (tepotinib hydrochloride) drug patents, SPCs, drug

      ¥3,163券后¥3,3230人已购买
      优惠券¥160 领券购买 
    • 预订 XIGDUO XR (dapagliflozin; metformin hydrochloride) Drug Profile, 2025: XIGDUO XR (dapagliflozin; metformin hydrochl

      dapagliflozinmetforminXIGDUOhydrochloride

      预订 XIGDUO XR (dapagliflozin; metformin hydrochloride) Drug Profile, 2025: XIGDUO XR (dapagliflozin; metformin hydrochl

      ¥3,163券后¥3,3230人已购买
      优惠券¥160 领券购买 
    • 预订 BIJUVA (estradiol; progesterone) Drug Profile, 2025: BIJUVA (estradiol; progesterone) drug patents, litigation, SPC

      progesteroneestradiolBIJUVADrug

      预订 BIJUVA (estradiol; progesterone) Drug Profile, 2025: BIJUVA (estradiol; progesterone) drug patents, litigation, SPC

      ¥3,164券后¥3,3240人已购买
      优惠券¥160 领券购买 
    • 预订 SPINRAZA (nusinersen sodium) Drug Profile, 2025: SPINRAZA (nusinersen sodium) drug patents, SPCs, clinical trials,

      nusinersenSPINRAZAsodiumDrug

      预订 SPINRAZA (nusinersen sodium) Drug Profile, 2025: SPINRAZA (nusinersen sodium) drug patents, SPCs, clinical trials,

      ¥3,164券后¥3,3240人已购买
      优惠券¥160 领券购买 
    • 预订 SYNJARDY XR (empagliflozin; metformin hydrochloride) Drug Profile, 2025: SYNJARDY XR (empagliflozin; metformin hydr

      empagliflozinmetforminSYNJARDYhydrochloride

      预订 SYNJARDY XR (empagliflozin; metformin hydrochloride) Drug Profile, 2025: SYNJARDY XR (empagliflozin; metformin hydr

      ¥3,165券后¥3,3250人已购买
      优惠券¥160 领券购买 
    • 预订 VOSEVI (sofosbuvir; velpatasvir; voxilaprevir) Drug Profile, 2025: VOSEVI (sofosbuvir; velpatasvir; voxilaprevir) d

      voxilaprevirvelpatasvirsofosbuvirVOSEVI

      预订 VOSEVI (sofosbuvir; velpatasvir; voxilaprevir) Drug Profile, 2025: VOSEVI (sofosbuvir; velpatasvir; voxilaprevir) d

      ¥3,165券后¥3,3250人已购买
      优惠券¥160 领券购买 
    • 预订 VELTASSA (patiromer sorbitex calcium) Drug Profile, 2025: VELTASSA (patiromer sorbitex calcium) drug patents, litig

      patiromerVELTASSAsorbitexcalcium

      预订 VELTASSA (patiromer sorbitex calcium) Drug Profile, 2025: VELTASSA (patiromer sorbitex calcium) drug patents, litig

      ¥3,166券后¥3,3260人已购买
      优惠券¥160 领券购买 
    • 预订 SUNOSI (solriamfetol hydrochloride) Drug Profile, 2025: SUNOSI (solriamfetol hydrochloride) drug patents, litigatio

      hydrochloridesolriamfetolSUNOSIDrug

      预订 SUNOSI (solriamfetol hydrochloride) Drug Profile, 2025: SUNOSI (solriamfetol hydrochloride) drug patents, litigatio

      ¥3,169券后¥3,3290人已购买
      优惠券¥160 领券购买 
    • 预订 STRIVERDI RESPIMAT (olodaterol hydrochloride) Drug Profile, 2025: STRIVERDI RESPIMAT (olodaterol hydrochloride) dru

      hydrochlorideolodaterolSTRIVERDIRESPIMAT

      预订 STRIVERDI RESPIMAT (olodaterol hydrochloride) Drug Profile, 2025: STRIVERDI RESPIMAT (olodaterol hydrochloride) dru

      ¥3,169券后¥3,3290人已购买
      优惠券¥160 领券购买 
    • 预订 TIBSOVO (ivosidenib) Drug Profile, 2025: TIBSOVO (ivosidenib) drug patents, litigation, PTAB cases, SPCs, clinical

      ivosidenibTIBSOVODruglitigation

      预订 TIBSOVO (ivosidenib) Drug Profile, 2025: TIBSOVO (ivosidenib) drug patents, litigation, PTAB cases, SPCs, clinical

      ¥3,169券后¥3,3290人已购买
      优惠券¥160 领券购买 
    • 预订 STEGLUJAN (ertugliflozin; sitagliptin phosphate) Drug Profile, 2025: STEGLUJAN (ertugliflozin; sitagliptin phosphat

      ertugliflozinsitagliptinSTEGLUJANphosphate

      预订 STEGLUJAN (ertugliflozin; sitagliptin phosphate) Drug Profile, 2025: STEGLUJAN (ertugliflozin; sitagliptin phosphat

      ¥3,169券后¥3,3290人已购买
      优惠券¥160 领券购买 
    • 预订 TRINTELLIX (vortioxetine hydrobromide) Drug Profile, 2025: drug patents, patent challenges, litigation, SPCs, clini

      DrugvortioxetinehydrobromideTRINTELLIX

      预订 TRINTELLIX (vortioxetine hydrobromide) Drug Profile, 2025: drug patents, patent challenges, litigation, SPCs, clini

      ¥3,170券后¥3,3300人已购买
      优惠券¥160 领券购买 
    • 预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      sacubitrilvalsartanENTRESTODrug

      预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      ¥3,170券后¥3,3300人已购买
      优惠券¥160 领券购买 
    • 预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      eluxadolineVIBERZIDruglitigation

      预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      ¥3,171券后¥3,3310人已购买
      优惠券¥160 领券购买 
    • 预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      larotrectinibVITRAKVIsulfateDrug

      预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      ¥3,172券后¥3,3320人已购买
      优惠券¥160 领券购买 
    • 预订 EPCLUSA (sofosbuvir; velpatasvir) Drug Profile, 2025: EPCLUSA (sofosbuvir; velpatasvir) drug patents, litigation, P

      velpatasvirsofosbuvirEPCLUSADrug

      预订 EPCLUSA (sofosbuvir; velpatasvir) Drug Profile, 2025: EPCLUSA (sofosbuvir; velpatasvir) drug patents, litigation, P

      ¥3,173券后¥3,3330人已购买
      优惠券¥160 领券购买 
    • 预订 TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: TRIUMEQ PD (abacavir sulfate; do

      abacavirTRIUMEQsulfatedolutegravir

      预订 TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: TRIUMEQ PD (abacavir sulfate; do

      ¥3,174券后¥3,3340人已购买
      优惠券¥160 领券购买 
    • 预订 NINLARO (ixazomib citrate) Drug Profile, 2025: NINLARO (ixazomib citrate) drug patents, litigation, SPCs, clinical

      ixazomibNINLAROcitrateDrug

      预订 NINLARO (ixazomib citrate) Drug Profile, 2025: NINLARO (ixazomib citrate) drug patents, litigation, SPCs, clinical

      ¥3,176券后¥3,3360人已购买
      优惠券¥160 领券购买 
    • 预订 TAZVERIK (tazemetostat hydrobromide) Drug Profile, 2025: TAZVERIK (tazemetostat hydrobromide) drug patents, clinica

      tazemetostathydrobromideTAZVERIKDrug

      预订 TAZVERIK (tazemetostat hydrobromide) Drug Profile, 2025: TAZVERIK (tazemetostat hydrobromide) drug patents, clinica

      ¥3,176券后¥3,3360人已购买
      优惠券¥160 领券购买 
    上一页 1 ...  18   19  20  21   22  下一页